Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas
Launched by KLINIKUM STUTTGART · Aug 24, 2022
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas is a research project aimed at collecting important information about different types of bone cancers, specifically osteosarcomas. This study will gather data from patients to better understand these diseases, their outcomes, and long-term effects. Additionally, researchers will collect blood samples and tumor specimens to investigate the biological causes of osteosarcoma and explore new treatment options. If any genetic changes linked to the cancer are found, patients will be informed and may receive guidance on how this could affect their health.
To participate in this study, individuals must have specific types of bone tumors, such as high-grade osteosarcoma or other related sarcomas. All ages and genders can be included, as long as they provide informed consent to join the registry. While the study is not yet recruiting patients, those who do participate can expect to contribute to important research that may lead to improved treatments and understanding of these cancers.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • high-grade osteosarcoma (conventional and non-conventional)
- • parosteal, periosteal or extraosseous osteosarcoma
- • low grade central osteosarcoma
- • (osseous) Undifferentiated pleomorphic sarcoma (UPS)
- • (osseous) leiomyosarcoma
- • (osseous) dedifferentiated chondrosarcoma
- • (osseous) mesenchymal chondrosarcoma
- • (osseous) fibrosarcoma
- • (osseous) angiosarcoma
- • informed consent
- Exclusion Criteria:
- • no informed consent
About Klinikum Stuttgart
Klinikum Stuttgart is a leading academic medical center in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, Klinikum Stuttgart focuses on a wide range of medical fields, leveraging its state-of-the-art facilities and a multidisciplinary team of experts to enhance patient outcomes and contribute to the scientific community. With a dedication to ethical standards and patient safety, Klinikum Stuttgart plays a pivotal role in translating research findings into practical applications that benefit patients and improve healthcare practices globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials